506 related articles for article (PubMed ID: 25438287)
21. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
Parker R
Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding.
Schultheiss M; Bettinger D; Sturm L; Schmidt A; Backhus J; Waidmann O; Radecke K; Grandt D; Thimme R; Rössle M
Cardiovasc Intervent Radiol; 2022 May; 45(5):542-549. PubMed ID: 35020042
[TBL] [Abstract][Full Text] [Related]
23. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures.
Otal P; Smayra T; Bureau C; Peron JM; Chabbert V; Chemla P; Joffre F; Vinel JP; Rousseau H
AJR Am J Roentgenol; 2002 Jan; 178(1):141-7. PubMed ID: 11756108
[TBL] [Abstract][Full Text] [Related]
24. Transjugular intrahepatic portosystemic stent shunt.
Jalan R; Redhead DN; Hayes PC
Natl Med J India; 1995; 8(1):15-21. PubMed ID: 7696939
[TBL] [Abstract][Full Text] [Related]
25. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience.
Rossi P; Salvatori FM; Fanelli F; Bezzi M; Rossi M; Marcelli G; Pepino D; Riggio O; Passariello R
Radiology; 2004 Jun; 231(3):820-30. PubMed ID: 15118117
[TBL] [Abstract][Full Text] [Related]
26. The use of transjugular intrahepatic portosystemic stent shunt (TIPS) in the management of portal hypertensive bleeding.
Lo GH
J Chin Med Assoc; 2014 Aug; 77(8):395-402. PubMed ID: 25028297
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
[No Abstract] [Full Text] [Related]
28. [30 Years of Transjugular Intrahepatic Portosystemic Shunt (TIPS): casting a retrospective glance and future perspectives].
Schultheiß M; Bettinger D; Thimme R; Rössle M
Z Gastroenterol; 2020 Sep; 58(9):877-889. PubMed ID: 32947633
[TBL] [Abstract][Full Text] [Related]
29. Transjugular intrahepatic portosystemic shunt: current status.
Boyer TD
Gastroenterology; 2003 May; 124(6):1700-10. PubMed ID: 12761727
[TBL] [Abstract][Full Text] [Related]
30. Polytetrafluoroethylene-Covered Stent Graft Versus Bare Stent in Transjugular Intrahepatic Portosystemic Shunt: Systematic Review and Meta-Analysis.
Triantafyllou T; Aggarwal P; Gupta E; Svetanoff WJ; Bhirud DP; Singhal S
J Laparoendosc Adv Surg Tech A; 2018 Jul; 28(7):867-879. PubMed ID: 29356589
[TBL] [Abstract][Full Text] [Related]
31. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.
Tripathi D; Ferguson J; Barkell H; Macbeth K; Ireland H; Redhead DN; Hayes PC
Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):225-32. PubMed ID: 16462534
[TBL] [Abstract][Full Text] [Related]
32. Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives.
Rösch J; Keller FS
World J Surg; 2001 Mar; 25(3):337-45; discussion 345-6. PubMed ID: 11343189
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report].
Martínez Moreno B; Bellot P; de España F; Palazón JM; Such J; Pérez-Mateo M
Gastroenterol Hepatol; 2011; 34(7):468-73. PubMed ID: 21652116
[TBL] [Abstract][Full Text] [Related]
34. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis.
Yang Z; Han G; Wu Q; Ye X; Jin Z; Yin Z; Qi X; Bai M; Wu K; Fan D
J Gastroenterol Hepatol; 2010 Nov; 25(11):1718-25. PubMed ID: 21039832
[TBL] [Abstract][Full Text] [Related]
35. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
36. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
[TBL] [Abstract][Full Text] [Related]
37. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
[TBL] [Abstract][Full Text] [Related]
38. Evolving Indications for Tips.
Smith M; Durham J
Tech Vasc Interv Radiol; 2016 Mar; 19(1):36-41. PubMed ID: 26997087
[TBL] [Abstract][Full Text] [Related]
39. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
[TBL] [Abstract][Full Text] [Related]
40. Transjugular intrahepatic portosystemic shunt: where are we?
Altun R; Yıldırım E; Ocal S; Akbaş E; Harman A; Kormaz M; Selçuk H
Turk J Gastroenterol; 2014 Jun; 25(3):298-303. PubMed ID: 25141319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
